SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950170-24-047951
Filing Date
2024-04-25
Accepted
2024-04-25 09:05:03
Documents
4
Group Members
KAYAK MERGECOTUHURA BIOSCIENCES, INC.

Document Format Files

Seq Description Document Type Size
1 425 ktra_8k_425_asco_apr_202.htm 425 65823
2 EX-99.1 ktra-ex99_1.htm EX-99.1 34354
3 GRAPHIC img40499469_0.jpg GRAPHIC 123916
4 GRAPHIC img40499469_1.jpg GRAPHIC 91811
  Complete submission text file 0000950170-24-047951.txt   399519
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filed by) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-37823 | Film No.: 24873258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)